Targeted PEG-based bioconjugates enhance the cellular uptake and transport of a HIV-1 TAT nonapeptide
Authors:
- Bo QiuBQBo Qiu
- Shahriar PooyanSPShahriar Pooyan
- Guobao ZhangGZGuobao Zhang
- Stanley SteinSSStanley Stein
- Michael J LeibowitzMLMichael J Leibowitz
- Patrick.J SinkoPatrick.J Sinko
- 1 December 2001
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 77 (3) , 199-212
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Novel Approaches for Oral Delivery of MacromoleculesJournal of Pharmaceutical Sciences, 1998
- Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, ValacyclovirBiochemical and Biophysical Research Communications, 1998
- Modulation of Intestinal Permeability: An Innovative Method of Oral Drug Delivery for the Treatment of Inherited and Acquired Human DiseasesMolecular Genetics and Metabolism, 1998
- The challenge of proteolytic enzymes in intestinal peptide deliveryJournal of Controlled Release, 1997
- Absorption of Peptide and Peptidomimetic DrugsAnnual Review of Pharmacology and Toxicology, 1994
- Mechanisms of absorption enhancement and tight junction regulationJournal of Controlled Release, 1994
- Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugsJournal of Controlled Release, 1994
- Structural Specificity of Mucosal-Cell Transport and Metabolism of Peptide Drugs: Implication for Oral Peptide Drug DeliveryPharmaceutical Research, 1992
- Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cellsJournal of Cell Biology, 1992
- Penetration and enzymatic barriers to peptide and protein absorptionAdvanced Drug Delivery Reviews, 1989